Dates: September 22-25, 2017
Location: W Hotel, Seattle, WA
Download the course brochure for more information on the course.
This 3.5-day program will cover data supporting guidelines, recommendations, and recent advances regarding therapeutic options for patients with solid tumors and hematologic disorders. At the end of the course, physicians will leave with a comprehensive syllabus, a self-assessment, and a deeper understanding of the pathogenesis, diagnostic evaluation, and therapeutic modalities available for a breadth of solid tumors as well as hematologic disorders. There will be a case-based review session and discussions. The course will be designed to help prepare you for certifying and re-certifying exams as applicable.
- Describe the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common malignant hematological diseases.
- Describe the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common solid tumor malignancies.
- Integrate guideline-based treatments into clinical practice while personalizing care appropriately for the patient.
- Integrate new therapeutic and diagnostic approaches into clinical practice as appropriate.
The target audience for this activity will be physicians and allied health professionals with a hematology/oncology focus who desire a review and update in current standards of care for patients. The course will be helpful to those preparing for certification or re-certification.